Cryopreserved allograft repair of aortic hypoplasia and interrupted aortic arch

Mortality for interruption of the aortic arch approaches 100% within the first year of life if untreated. Prostaglandin E 1 can stabilize the patient's condition in anticipation of surgical palliation, but total repair is required for long-term survival. Successful complete repair of type B int...

Full description

Saved in:
Bibliographic Details
Published inThe Annals of thoracic surgery Vol. 53; no. 6; pp. 1110 - 1113
Main Authors St. Cyr, John A., Campbell, David N., Fullerton, David A., Grosso, Michael, Bishop, Deborah A., Clarke, David R.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.06.1992
Elsevier Science
Subjects
Aorta, Thoracic - abnormalities
Aorta, Thoracic - surgery
Aortic Valve - transplantation
Biological and medical sciences
Cardiology. Vascular system
Congenital heart diseases. Malformations of the aorta, pulmonary vessels and vena cava
Cryopreservation
Heart
Heart Defects, Congenital - surgery
Humans
Infant, Newborn
Male
Medical sciences
Methods
Palliative Care
Reoperation
Hypoplasia
Plasty
Treatment
Ventricular septal defect
Congenital
Heart disease
Surgery
Homograft
Cardiovascular disease
Technique
Left ventricle
Online AccessGet full text

Cover

More Information
Summary:Mortality for interruption of the aortic arch approaches 100% within the first year of life if untreated. Prostaglandin E 1 can stabilize the patient's condition in anticipation of surgical palliation, but total repair is required for long-term survival. Successful complete repair of type B interrupted aortic arch, hypoplasia of the left ventricular outflow tract, and ventricular septal defect was possible using a cryopreserved allograft in a child who previously had undergone unusual palliation.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0003-4975
1552-6259
DOI:10.1016/0003-4975(92)90402-P